AGP
PFE icon

Autumn Glory Partners’s Pfizer PFE Stock Holding History

Autumn Glory Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8M Buy
64,186
+11,301
+21% +$301K 0.66% 39
2025
Q4 		$1.32M Buy
52,885
+15,010
+40% +$379K 0.46% 64
2025
Q3 		$965K Hold
37,875
– – 0.4% 72
2025
Q2 		$918K Hold
37,875
– – 0.43% 67
2025
Q1 		$960K Sell
37,875
-1,284
-3% -$33.6K 0.48% 61
2024
Q4 		$1.05M Buy
39,159
+8,909
+29% +$242K 0.51% 60
2024
Q3 		$875K Buy
30,250
+16,875
+126% +$492K 0.34% 80
2024
Q2 		$374K Buy
13,375
+2,355
+21% +$64.8K 0.19% 107
2024
Q1 		$306K Buy
+11,020
New +$306K 0.15% 119
2023
Q3 		– Sell
-8,760
Closed -$321K – 164
2023
Q2 		$321K Buy
+8,760
New +$341K 0.24% 97
2023
Q1 		– Sell
-18,459
Closed -$946K – 172
2022
Q4 		$946K Buy
18,459
+8,471
+85% +$406K 0.51% 60
2022
Q3 		$437K Sell
9,988
-4,739
-32% -$230K 0.29% 85
2022
Q2 		$772K Buy
14,727
+5,145
+54% +$262K 0.57% 52
2022
Q1 		$496K Sell
9,582
-6,713
-41% -$348K 0.29% 99
2021
Q4 		$963K Buy
+16,295
New +$807K 0.4% 68

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Autumn Glory Partners's PFE Position: Q1 2026 in Review

Autumn Glory Partners increased its Pfizer (PFE) stake by 21% in Q1 2026, buying an estimated $301K and bringing the position to 64,186 shares worth $1.8M. The position accounts for 0.66% of the portfolio, ranked #39.

Autumn Glory Partners first reported a position in PFE in Q4 2021 and has held it in 15 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Autumn Glory Partners held 64,186 shares of Pfizer worth $1.8M as of Q1 2026.
  • Autumn Glory Partners bought 11,301 Pfizer shares in Q1 2026, an estimated $301K.
  • Pfizer made up 0.66% of Autumn Glory Partners's portfolio in Q1 2026, its #39 holding.
  • Autumn Glory Partners first reported a position in Pfizer in Q4 2021 and has held it in 15 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Autumn Glory Partners's 13F filing for Q1 2026, filed 4 May 2026.